nejm.org
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes | NEJM
Orforglipron is a small-molecule, nonpeptide glucagon-like peptide-1 (GLP-1) receptor
agonist in clinical development for type 2 diabetes and weight management. Additional
data on the efficacy and ...